Discover 32 paid clinical trials in Laramie, Wyoming. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 32
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Cheyenne WY, Denver CO, Salt Lake City UT, Pierre SD,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
for
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Examining the Effectiveness of Dynamic Visual Noise (DVN) for Reducing Alcohol Cravings and Consumption in College Students
for
Craving, Alcohol Drinking
Location: Laramie WY
Sponsor: University of Wyoming
Sex: All
Age: 18 - 29
Code: NCT07157124
Recruiting
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
for
Amblyopia
Location: Laramie WY, Salt Lake City UT, Omaha NE, Boise ID,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 3 - 13
Code: NCT04378790
Phase3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Cheyenne WY, Fort Collins CO, Loveland CO, Greeley CO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061964
Phase2, Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for
Prostate Cancer (Adenocarcinoma)
Location: Cheyenne WY, Fort Collins CO, Loveland CO, Greeley CO,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06592924
Phase3, Recruiting
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer